Characterization of the human zinc finger nfx‑1‑type containing 1 encoding ZNFX1 gene and its response to 12‑O‑tetradecanoyl‑13‑acetate in HL‑60 cells.


Journal

International journal of oncology
ISSN: 1791-2423
Titre abrégé: Int J Oncol
Pays: Greece
ID NLM: 9306042

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 06 02 2019
accepted: 19 07 2019
pubmed: 23 8 2019
medline: 6 2 2020
entrez: 22 8 2019
Statut: ppublish

Résumé

Human promyelocytic HL‑60 cells can be differentiated into macrophage‑like cells by treatment with 12‑O‑tetra decanoylphorbol‑13‑acetate (TPA). Certain 5' upstream regions of the zinc finger protein (ZNF)‑encoding genes contain duplicated GGAA motifs, which are frequently found in the TPA‑responding gene promoter regions. To examine transcriptional responses to TPA, 5'flanking regions of human zinc finger CCCH‑type containing, antiviral, ZNF252, ZNF343, ZNF555, ZNF782 and zinc finger nfx‑1‑type containing 1 (ZNFX1) genes were isolated by polymerase chain reaction (PCR) and ligated into a multiple‑cloning site of the pGL4.10[luc2] vector. Transient transfection and a luciferase assay revealed that the ZNFX1 promoter most prominently responded to the TPA treatment. Deletion and point mutation experiments indicated that the duplicated GGAA motif in the 100‑bp region positively responded to TPA. In addition, reverse transcription‑quantitative PCR and western blotting showed that the mRNA and protein of ZNFX1 accumulate during the differentiation of HL‑60 cells. These results indicated that expression of the TPA‑inducible ZNFX1 gene, which belongs to the group of interferon‑responsive genes, is regulated by the cis‑action of the duplicated GGAA motif.

Identifiants

pubmed: 31432148
doi: 10.3892/ijo.2019.4860
doi:

Substances chimiques

Antigens, Neoplasm 0
ZNFX1 protein, human 0
Tetradecanoylphorbol Acetate NI40JAQ945

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

896-904

Auteurs

Hiroshi Hamada (H)

Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda‑shi, Chiba‑ken 278‑8510, Japan.

Mayu Yamamura (M)

Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda‑shi, Chiba‑ken 278‑8510, Japan.

Hiroto Ohi (H)

Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda‑shi, Chiba‑ken 278‑8510, Japan.

Yota Kobayashi (Y)

Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda‑shi, Chiba‑ken 278‑8510, Japan.

Kuniyoshi Niwa (K)

Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda‑shi, Chiba‑ken 278‑8510, Japan.

Takahiro Oyama (T)

Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda‑shi, Chiba‑ken 278‑8510, Japan.

Yasunari Mano (Y)

Department of Clinical Drug Informatics, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda‑shi, Chiba‑ken 278‑8510, Japan.

Masashi Asai (M)

Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda‑shi, Chiba‑ken 278‑8510, Japan.

Sei-Ichi Tanuma (SI)

Department of Biochemistry, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda‑shi, Chiba‑ken 278‑8510, Japan.

Fumiaki Uchiumi (F)

Department of Gene Regulation, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda‑shi, Chiba‑ken 278‑8510, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH